Lemon Bottle (Lipolysis Injection)
Lemon Bottle
Brand-name lipolysis injection combining riboflavin and other lipotropic ingredients for localized fat.
Key takeaways
- Brand-name fat-dissolving injection listing riboflavin, bromelain, and lecithin as actives.
- Not FDA-approved; unlike Kybella (deoxycholic acid), there's no approval or controlled-trial evidence.
- Skin necrosis, nodules, and uneven results are reported with unregulated lipolysis injections.
Composition
| Ingredient | Amount | Role |
|---|---|---|
| Riboflavin (vitamin B2) | Not disclosed | Vendor-claimed metabolic cofactor |
| Bromelain | Not disclosed | Pineapple-derived proteolytic enzyme |
| Lecithin | Not disclosed | Phospholipid; vendor-claimed fat emulsifier |
Reported dosing protocols
Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.
| Use case | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Localized fat (vendor protocol) | Varies by treatment area | SubQ, injected into fat | Weekly sessions | 3–5 sessions reported |
Frequently asked questions
Is Lemon Bottle FDA-approved?
No. The only FDA-approved injectable for localized fat is deoxycholic acid (Kybella), approved for submental (under-chin) fat. Lemon Bottle is sold without US regulatory approval, and its listed ingredients haven't been tested in controlled trials for fat reduction.
Does Lemon Bottle actually dissolve fat?
There's no independent clinical evidence that it does. The claims come from vendor materials and practitioner testimonials. Reported problems with unregulated lipolysis injections include skin necrosis, nodules, and uneven contour results.
Why isn't Lemon Bottle in the plotter?
It's a multi-ingredient cosmetic injection with no single half-life or dose-concentration relationship to model. The plotter only handles compounds with a defined PK curve.
References
- Vendor product (informational) — Brand fat-dissolving injection (riboflavin + lipotropics); not plotted.
Related compounds
Semaglutide Injection (Ozempic/Wegovy)
Long-acting GLP-1 receptor agonist for type 2 diabetes and weight loss; weekly injection.
Semaglutide Oral (Rybelsus)
Oral semaglutide with very low bioavailability; taken fasting.
Tirzepatide (Mounjaro)
Dual GIP/GLP-1 agonist for weight loss and diabetes; weekly injection, strong efficacy.
Comments
Loading comments…